Biodegradable ROS-Responsive TPCD Nanoparticles Mitigate Cisplatin-Induced Acute Kidney Injury via Synergistic Antioxidant and Immunomodulatory Actions
TPCD NPs demonstrate renoprotective effects in cisplatin-induced AKI, likely via combined antioxidant, anti-apoptotic, and immunomodulatory actions, and long-term safety and efficacy in other AKI models remain to be established.